StonvexLoading…
StonvexStonvexStonvexCore line items from VKTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-164.13M | $-393.34M | $-228.60M | $-130.04M |
Net Income | $-158.32M | $-359.64M | $-201.98M | $-111.19M |
EPS (Diluted) | $-1.37 | $-3.19 | $-1.80 | $-0.99 |
Total Assets | $608.24M | $715.73M | $739.41M | $827.85M |
Total Liabilities | $106.33M | $76.67M | $26.39M | $32.39M |
Cash & Equivalents | $118.12M | $165.81M | $100.38M | $33.88M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 115.89M | 114.79M | 112.45M | 112.33M |